Pharmafile Logo
Pharmafocus logo
Advanced Search
bristol

Opdivo first PD-1 inhibitor given European approval for haematological cancer

November 25, 2016
Medical Communications, Sales and Marketing BMS, Bristol-Myers Squibb, EMA, PD1-Inhibitor, bristol myers-squibb

Bristol-Myers Squibb announced that it has received the first and only European approval for a PD1 inhibitor in the treatment …

News
celgene_1_02

NICE u-turns on Celgene’s drug for multiple myeloma

November 24, 2016
Medical Communications Celgene, NICE, imnovid

NICE has performed a U-turn on Celgene’s Imnovid (pomalidomide) based on new data and the offer of a price reduction. …

News

Woodley Equipment Exhibiting at Clinical Operations in Oncology Trials Europe

November 24, 2016
clinical research, clinicaltrials, oncology

Woodley Equipment is exhibiting at Clinical Operations in Oncology Trials Europe, which is taking place on 29th and 30th November Steigenberger …

News
Press release
shutterstock_231613360

Non-small cell lung cancer market to hit $26bn by 2025

November 24, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GlobalData, non-small cell lung cancer

New research from GlobalData has indicated that the non-small cell lung cancer (NSCLC) market will rise in value by over …

News
navidea_cmyk

Navidea agrees deal worth $310 million with Cardinal

November 24, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cardinal, Navidea, Navidea biopharmaceutical

Navidea Biopharmaceuticals, a developer of immunodiagnostic agents and immunotherapeutics, has announced that they will enter into a definitive asset purchase …

News
juno

Patient deaths lead Juno Therapeutics to halt trial for second time

November 24, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing acute lymphoblastic leukaemia, clinical trial deaths, juno therapeutics

Juno Therapeutics has been forced to halt a trial investigating the efficacy of its lead experimental CAR-T cancer treatment JCAR015 …

News
lilly2_web

Lilly forced to abandon Alzheimer’s drug after failed trial

November 24, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Alzheimer's disease, Eli Lilly

Eli Lilly announced that the results of its ‘Expedition 3’ trial for an experimental Alzheimer’s disease drug meant that they would …

News
allergan

Allergan acquires Chase Pharma in potential $1 billion deal

November 23, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Allergan announced that it has completed the acquisition of Chase Pharmaceutical Corporation in a deal worth a potential $1 billion. …

News
anthony_maddaluna

Anthony Maddaluna, executive vice president of Pfizer, to retire

November 23, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Anthony J. Maddaluna, who worked at Pfizer for more than 41 years, will retire from his positions of executive vice …

Appointment
sun_pharma

Sun Pharma makes strategic Russian firm acquisition

November 23, 2016
Research and Development, Sales and Marketing Biosintez, Russia, Sun Pharma

Sun Pharmaceutical, India’s largest pharmaceutical company, has acquired Russian pharmaceutical company JSC Biosintez in a total deal of $60 million. …

News

Pfizer set to develop new $200 million site

November 23, 2016
Manufacturing and Production, Research and Development Pfizer, manufacturing and production

Pfizer plans to expand its operations in St. Louis, Missouri, by developing a $200 million facility in Chesterfield. The site …

News

Scientists identify an existing drug that could aid in therapy for brain swelling

November 23, 2016
Medical Communications, Research and Development University of Arkansas, concussion, head injury

A team of biomedical engineering researches, who performed their study at the University of Arkansas, have identified a drug that …

News
shutterstock_141299494

University of Toronto develops circulating tumour cell monitoring tool

November 22, 2016
Research and Development University of Toronto, circulating cancer cells

Researchers at the University of Toronto have developed a new tool which promises to enable the monitoring and profiling of …

News
thomas_willemsen

Thomas Willemson promoted to China Area Head at GSK

November 22, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

GlaxoSmithKline appointed a new area head in Thomas Willemsen to take charge of its China drug business. He succeeds Herve …

Appointment
jj_2johnson_and_johnson

J&J and Genmab’s drug races to second line treatment approval

November 22, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Genmab, Janssen, Johnson & Johnson, darzalex, multiple myeloma

Janssen, a part of Johnson & Johnson, and Genmab have announced that their multiple myeloma drug Darzalex (daratumumab) has been …

News

Mylan ducks call to testify in front of Senate

November 22, 2016
Manufacturing and Production, Medical Communications Department of Justice, Mylan, epipen

Mylan has avoided the call to testify in front of the Senate judiciary committee. The hearing will be convened under …

News
fdaoutsideweb

Sanofi and Novo to face off in diabetes sphere following FDA approvals

November 22, 2016
Manufacturing and Production, Sales and Marketing FDA, Novo Nordisk, Sanofi, Soliqua, Xultophy, diabetes

Sanofi and Novo are set to face off in the diabetes market after the FDA approved combination treatments from the …

News
astrazeneca_building_white

AstraZeneca allowed to recruit for drug trial again

November 22, 2016
Manufacturing and Production, Research and Development AstraZeneca, FDA, clinical trial

AstraZeneca’s clinical trial for head and neck cancer had previously been put on partial hold by the FDA due to …

News
theresa_may

Theresa May promises £2 billion a year in funding for R&D

November 21, 2016
Manufacturing and Production, Medical Communications Conservative, Theresa May, brexit

The Conservative Party leader has announced a planned raise in funding for research and development for UK business to £2 …

News

Acorda forced to stop development of drug

November 21, 2016
Manufacturing and Production, Research and Development Acorda therapeutics, clinical trial, post-stroke

Acorda Therapeutics announced that they were unable to continue development of the drug, dalfampridine, due to lack of efficacy in …

News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026